A Curated Bibliography of Phage Therapy and Phage-Mediated Biocontrol Publications
by Stephen T. Abedon Ph.D.Steve Abedon, Ph.D., has taught well over 100 individual classes and ~10 individual courses over his 30+ years as a college professor. He has over 150 publications, including multiple monographs, and is ranked in the top 1 or 2 percent among researchers of all disciplines worldwide. His research focuses on bacteriophage biology and phage therapy. (abedon.1@osu.edu)
phage.org | phage-therapy.org | biologyaspoetry.org | abedon.phage.org | google scholar | publications
Jump to: ✨ New | 📅 Year Index | 📚 Entries | 🏥 Clinical Studies | 🔍 Search | 🦠 Targets & Systems | 📈 Statistics | 📄 Journals | 🔭 Find Missing | 💌 Suggest | 💡 The Challenge | 🧮 More Calculators
literome.phage-therapy.org · Abedon’s Books · DOI: 10.5281/zenodo.21251507
How can I improve this page? contact: literome@phage-therapy.org
What has most recently joined the Literome. The collection is revised monthly, so this is where to look first if you have visited before.
Click any title to reveal links for finding it in PubMed, Google Scholar, Europe PMC and Crossref, along with its DOI where one is held.
5,806 entries spanning 1896–2027. Click a decade to expand it, then click a year to load that year’s entries. Entries within each year are listed in ascending-author order. — 🔍 Search all years →
Clinical studies as curated by S.T. Abedon. 224 entries spanning 1921–2026. See the Clinical Studies tab for the full list. Clinical entries are a subset of the full Literome bibliography.
Click any title to reveal links for finding it in PubMed, Google Scholar, Europe PMC and Crossref, along with its DOI where one is held. Check entries to download them in your preferred format. Entries listed as in press lack final volume/page data at time of compilation. — 🔍 Search all years →
Loading 2026 entries…
224 curated clinical phage therapy studies spanning 1921–2026, maintained by S.T. Abedon. These represent cases where phages were actually administered to patients or animals in a clinical or veterinary context. Select a year to browse entries. Entries can be downloaded using the same options as the main Entries tab.
Select a year:
Click any title to reveal links for finding it in PubMed, Google Scholar, Europe PMC and Crossref, along with its DOI where one is held.
Loading clinical entries…
Search across all entries in the Literome. All year files load when you open this tab (~1.1 MB total compressed); subsequent searches are instant. To send someone a search, use Copy a link to this search beside the box; the address in your browser’s address bar also follows the search as you type. Results show titles and citations. Click any title to reveal links for finding it in PubMed, Google Scholar, Europe PMC and Crossref, along with its DOI where one is held.
Filter the Literome by the bacterium a publication targets, the experimental system it used, and whether it concerns biofilms, food and agriculture, or clinical treatment of people. Selections combine, so you can ask for Klebsiella in a mouse model, or Pseudomonas and biofilms in the same study.
Click any title to reveal links for finding it in PubMed, Google Scholar, Europe PMC and Crossref, along with its DOI where one is held.
Chart how the literature has grown, either as a whole or for any slice of it you care to define. Build a line for Staphylococcus, another for Pseudomonas, and compare them; or ask what share of each year's publications concerned biofilms, or mouse models, or clinical treatment.
All journals represented in the Literome bibliography, with entry counts and year ranges. Click any journal to filter entries from that journal in the Search tab.
| # | Full Name | Abbreviation | Entries | Years |
|---|---|---|---|---|
| Loading journals… | ||||
Many phage therapy and phage biocontrol publications never use the words “phage therapy” or “bacteriophage therapy.” Food safety papers in particular tend to speak of biocontrol, biological control, biopreservation, or decontamination instead (see The Challenge). This tab searches PubMed, Europe PMC, and OpenAlex for phage publications that use such terms, compares every result with the Literome, and lists only those that the Literome does not already hold. You read through them, tick the ones that belong, and download those in a format that reference managers import (RIS, MEDLINE, or BibTeX).
Whether a publication belongs is still a judgment: most results will be phage isolation or characterization papers that go no further than killing bacteria in broth (see the inclusion criteria under Suggest). The search terms below are a starting point and can be edited; your edits are remembered in this browser.
Searching sends the search terms below (not anything about you) from your browser to PubMed, Europe PMC, and OpenAlex. An email address, if you give one, is sent along with the searches, as these services ask of anyone making many requests. Nothing is stored anywhere except in this browser.
A publication is found when its title, abstract, or keywords contain at least one phage term and at
least one application term from the groups that are switched on, and none of the terms to leave
out. Put one term per line. Phrases need no quotation marks. An asterisk matches any ending
(bacteriophage* finds bacteriophage and bacteriophages); OpenAlex ignores asterisks but matches
plurals on its own.
0 ticked. Ticked publications download in the format your reference manager imports. Reference Manager, EndNote, Zotero, and Mendeley all import RIS; MEDLINE is PubMed’s own format.
If you know of a publication that belongs in the Phage Therapy Literome but is not yet listed, please use this form to suggest it. Before submitting, please search to confirm the entry is genuinely missing.
Enter keywords from the title or author name to check whether the reference is already listed:
If you have confirmed the reference is missing, please complete the form below. The fastest route to a complete citation is a DOI — if you have one, that alone is sufficient.
Suggestions are reviewed monthly. Thank you for helping make the Literome more complete.
Phage therapy has been studied for over a century, but it has never existed as a tightly coherent field with uniform terminology. Anyone who wants to use phages to control bacteria — whether in clinical medicine, veterinary practice, agriculture, aquaculture, or food safety — is potentially doing phage therapy or phage-mediated biocontrol of bacteria. That breadth of participation means the literature is scattered across an unusually wide range of journals and does not always use consistent terminology. As a result, no single database search will capture the complete literature.
An equally important problem is the opposite of missing publications: many papers that use phrases like “phage therapy” or “bacteriophage therapy” in their titles, abstracts, or keywords do not actually belong in a phage therapy bibliography. Demonstrating that a phage can kill bacteria in liquid culture, in a spot test on a lawn, or by forming plaques generally is more akin to phage or phage host-range characterization than specifically to phage therapy. To be included here, a publication instead must describe phage activity that goes beyond simply showing that the phage kills the bacterium or multiple bacteria under straightforward in vitro conditions.
For inclusion in this bibliography, a publication generally must describe the use of phages to reduce or control bacteria in a context beyond simple in vitro killing in broth, spot testing on lawns, or plaque formation. Examples of qualifying contexts include:
Publications describing phage isolation and characterization, including host-range testing, that go no further than broth killing, spot tests, or plaque assays are generally not included, even when authors describe their phage as a potential therapeutic agent.
PubMed is the most reliable starting point for biomedical phage therapy literature, but two separate searches are necessary because authors and indexers use both terms with no consistent preference:
“phage therapy”“bacteriophage therapy”
Running both and combining results will capture significantly more than either alone. Note that PubMed does not index all journals, and coverage of older literature and non-US journals is uneven.
For biocontrol applications — aquaculture, food safety, plant disease — additional searches are needed, but be aware that “biocontrol” and “biological control” are broad terms used in fields that have nothing to do with phages. Even restricting to “phage biocontrol” will return noise, and many authors who use phages for biocontrol do not use those terms at all, preferring “control,” “treatment,” “reduction,” or simply describing the application without a category label.
phage “biological control”bacteriophage biocontrol
The Find Missing tab runs searches of this kind, with many more application terms, across PubMed, Europe PMC, and OpenAlex at once, and sets aside whatever the Literome already holds.
Google Scholar indexes a much wider range of journals than PubMed, including many covering veterinary, agricultural, and aquaculture applications. It is especially useful for older literature and publications from journals not indexed in PubMed. Use the same search terms, and make use of Google Scholar’s “cited by” feature to find work that builds on key papers.
Europe PMC (europepmc.org) is freely available and provides broader coverage than PubMed for European journals and older literature — relevant given that much of the foundational phage therapy research originated in Eastern Europe and the UK.
Crossref (search.crossref.org) is useful for locating DOIs, particularly for journals not well indexed elsewhere. If you have a partial citation to verify or complete, a Crossref title search is often the most reliable option.
Anyone working with a specific bacterial target or phage type should search not only for “phage therapy” broadly, but also for their specific organism or phage. A researcher using T4-like phages against Escherichia coli, for example, should be aware of everything done with T4-like phages against E. coli in therapeutic or biocontrol contexts — regardless of whether those papers use “phage therapy” as a term. The relevant prior work may be indexed under organism names alone. Searching on organism and phage names directly, not just field-level terms, is essential for finding everything relevant to your work.
The core challenge this bibliography addresses is the mismatch between what database searches return and what actually constitutes phage therapy or biocontrol literature. These live examples illustrate the problem:
Distinguishing genuine phage therapy and biocontrol publications from this noise — and from publications that merely use the terminology without doing the work — is the primary purpose of this bibliography.
The term “literome” as applied to the bacteriophage literature was coined by Ryland Young (Texas A&M University). This bibliography represents approximately 30 years of ongoing literature tracking. The complete collection (1915–present, 5,654 entries) is available as a downloadable PDF and via the original Literome archive. For background on the challenges of searching the phage therapy literature, see:
Alves, D.R., and S.T. Abedon. 2017. An online phage therapy bibliography: separating under-indexed wheat from overly indexed chaff. AIMS Microbiology 3(3):525–528. 10.3934/microbiol.2017.3.525
The records are being checked against Crossref and other bibliographic databases using the Biology as Poetry Reference Checker, which compares each record’s first author, year, journal, volume, issue, and pages with those of the matching database record. Where a record has no DOI, the matching record’s DOI is added, but only when the two agree on every detail the record holds. So far the checker has supplied DOIs for several hundred records.
Checking is still under way. Differences the checker has reported in other details are not yet all resolved, so some records may still lack a DOI that exists, or contain an error in a year, volume, or page range. Errors noticed in any record are welcome at literome@phage-therapy.org.